Optimal reactive oxygen species concentration and p38 MAP kinase are required for coronary collateral growth.

Rocic, Petra

Optimal reactive oxygen species concentration and p38 MAP kinase are required for coronary collateral growth. [electronic resource] - American journal of physiology. Heart and circulatory physiology Jun 2007 - H2729-36 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

0363-6135

10.1152/ajpheart.01330.2006 doi


Acetophenones--pharmacology
Animals
Blood Flow Velocity
Cells, Cultured
Collateral Circulation--drug effects
Coronary Circulation--drug effects
Coronary Vessels--surgery
Disease Models, Animal
Ditiocarb--pharmacology
Endothelial Cells--drug effects
Enzyme Inhibitors--pharmacology
Humans
Imidazoles--pharmacology
Ligation
MAP Kinase Signaling System--drug effects
Male
Myocardial Reperfusion Injury--enzymology
NADPH Oxidases--antagonists & inhibitors
Neovascularization, Physiologic
Onium Compounds--pharmacology
Oxygenases--antagonists & inhibitors
Pyridines--pharmacology
Rats
Rats, Inbred WKY
Reactive Oxygen Species--metabolism
Superoxide Dismutase--antagonists & inhibitors
Vascular Endothelial Growth Factor A--metabolism
p38 Mitogen-Activated Protein Kinases--antagonists & inhibitors